Novartis reviews media: report

Novartis is launching a global media review, reported Advertising Age. The incumbent media shop is WPP's MEC, the magazine said, noting that in 2008, the company shifted its media business from WPP's Mindshare into MEC.
Novartis said in an email response: “We regularly evaluate suppliers, but have made no decision to change our media agency relationship at this time.” Ad Age cited “several industry executives” as saying the review was imminent and an RFP would go out shortly. GSK and Pfizer have reviewed their media planning and buying businesses recently, and with cost-cutting initiatives on at most major pharmas, they won't be the last.
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters


What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.


A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.